Jacquot Robin, Sève Pascal, Jackson Timothy L, Wang Tao, Duclos Antoine, Stanescu-Segall Dinu
Department of Internal Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon, Claude Bernard-Lyon 1 University, F-69004 Lyon, France.
Research on Healthcare Performance (RESHAPE), INSERM U1290, Claude Bernard Lyon 1 University, F-69000 Lyon, France.
J Clin Med. 2023 May 29;12(11):3746. doi: 10.3390/jcm12113746.
Recent years have seen the emergence and application of artificial intelligence (AI) in diagnostic decision support systems. There are approximately 80 etiologies that can underly uveitis, some very rare, and AI may lend itself to their detection. This synthesis of the literature selected articles that focused on the use of AI in determining the diagnosis, classification, and underlying etiology of uveitis. The AI-based systems demonstrated relatively good performance, with a classification accuracy of 93-99% and a sensitivity of at least 80% for identifying the two most probable etiologies underlying uveitis. However, there were limitations to the evidence. Firstly, most data were collected retrospectively with missing data. Secondly, ophthalmic, demographic, clinical, and ancillary tests were not reliably integrated into the algorithms' dataset. Thirdly, patient numbers were small, which is problematic when aiming to discriminate rare and complex diagnoses. In conclusion, the data indicate that AI has potential as a diagnostic decision support system, but clinical applicability is not yet established. Future studies and technologies need to incorporate more comprehensive clinical data and larger patient populations. In time, these should improve AI-based diagnostic tools and help clinicians diagnose, classify, and manage patients with uveitis.
近年来,人工智能(AI)已在诊断决策支持系统中出现并得到应用。葡萄膜炎可能有大约80种病因,其中一些非常罕见,而人工智能可能有助于对其进行检测。本文献综述选取了专注于人工智能在葡萄膜炎诊断、分类及潜在病因确定方面应用的文章。基于人工智能的系统表现出相对良好的性能,对葡萄膜炎最可能的两种潜在病因进行识别时,分类准确率为93%-99%,灵敏度至少为80%。然而,证据存在局限性。首先,大多数数据是回顾性收集的,存在数据缺失情况。其次,眼科检查、人口统计学数据、临床数据及辅助检查未可靠地整合到算法的数据集中。第三,患者数量较少,这在旨在区分罕见和复杂诊断时存在问题。总之,数据表明人工智能有作为诊断决策支持系统的潜力,但临床适用性尚未确立。未来的研究和技术需要纳入更全面的临床数据和更大的患者群体。假以时日,这些应能改进基于人工智能的诊断工具,并帮助临床医生对葡萄膜炎患者进行诊断、分类及管理。